These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 24431097

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Population pharmacokinetics of ceftaroline in patients with acute bacterial skin and skin structure infections or community-acquired bacterial pneumonia.
    Van Wart SA, Forrest A, Khariton T, Rubino CM, Bhavnani SM, Reynolds DK, Riccobene T, Ambrose PG.
    J Clin Pharmacol; 2013 Nov; 53(11):1155-67. PubMed ID: 23907740
    [Abstract] [Full Text] [Related]

  • 4. Ceftaroline fosamil: a new broad-spectrum cephalosporin.
    Laudano JB.
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii11-8. PubMed ID: 21482565
    [Abstract] [Full Text] [Related]

  • 5. Ceftaroline fosamil: a cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
    Poon H, Chang MH, Fung HB.
    Clin Ther; 2012 Apr; 34(4):743-65. PubMed ID: 22444785
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic/pharmacodynamic analysis to evaluate ceftaroline fosamil dosing regimens for the treatment of community-acquired bacterial pneumonia and complicated skin and skin-structure infections in patients with normal and impaired renal function.
    Canut A, Isla A, Rodríguez-Gascón A.
    Int J Antimicrob Agents; 2015 Apr; 45(4):399-405. PubMed ID: 25700566
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic and pharmacodynamic evaluation of ceftaroline fosamil.
    Merker A, Danziger LH, Rodvold KA, Glowacki RC.
    Expert Opin Drug Metab Toxicol; 2014 Dec; 10(12):1741-50. PubMed ID: 25347329
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens.
    Steed ME, Rybak MJ.
    Pharmacotherapy; 2010 Apr; 30(4):375-89. PubMed ID: 20334458
    [Abstract] [Full Text] [Related]

  • 10. Single-dose pharmacokinetic studies of abiraterone acetate in men with hepatic or renal impairment.
    Marbury T, Lawitz E, Stonerock R, Gonzalez M, Jiao J, Breeding J, Haqq C, Verboven P, Stieltjes H, Yu M, Molina A, Acharya M, Chien C, Tran N.
    J Clin Pharmacol; 2014 Jul; 54(7):732-41. PubMed ID: 24374856
    [Abstract] [Full Text] [Related]

  • 11. Ceftaroline fosamil for treatment of community-acquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapy.
    DiMondi VP, Drew RH, Chen LF.
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):567-72. PubMed ID: 21819323
    [Abstract] [Full Text] [Related]

  • 12. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.
    Biek D, Critchley IA, Riccobene TA, Thye DA.
    J Antimicrob Chemother; 2010 Nov; 65 Suppl 4():iv9-16. PubMed ID: 21115457
    [Abstract] [Full Text] [Related]

  • 13. Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia.
    Rank DR, Friedland HD, Laudano JB.
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii53-9. PubMed ID: 21482570
    [Abstract] [Full Text] [Related]

  • 14. Ceftaroline Dosage Optimized for Pediatric Patients With Renal Impairment Using Physiologically Based Pharmacokinetic Modeling.
    Zhou J, You X, Guo G, Ke M, Xu J, Ye L, Wu W, Huang P, Lin C.
    J Clin Pharmacol; 2021 Dec; 61(12):1646-1656. PubMed ID: 34329494
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ceftaroline fosamil: drug profile and clinical data.
    Kanafani ZA.
    Future Microbiol; 2011 Jan; 6(1):9-18. PubMed ID: 21162631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.